STOCK TITAN

Autolus Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Autolus Therapeutics (Nasdaq: AUTL) will participate in two investor events in March 2026. The company will present at the TD Cowen 46th Annual Health Care Conference on March 3, 2028 at 11:10am EST / 4:10pm GMT, with CEO Dr. Christian Itin presenting and a webcast available. A replay will be archived for 90 days. Management will host investor meetings at Jefferies Biotech on the Beach Summit on March 10, 2026 in Miami, FL.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – AUTL

+5.20%
13 alerts
+5.20% News Effect
+6.9% Peak Tracked
-4.7% Trough Tracked
+$25M Valuation Impact
$514M Market Cap
1.5x Rel. Volume

On the day this news was published, AUTL gained 5.20%, reflecting a notable positive market reaction. Argus tracked a peak move of +6.9% during that session. Argus tracked a trough of -4.7% from its starting point during tracking. Our momentum scanner triggered 13 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $25M to the company's valuation, bringing the market cap to $514M at that time.

Data tracked by StockTitan Argus on the day of publication.

LONDON and GAITHERSBURG, Md., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the Company will participate in two upcoming investor conferences.

TD Cowen 46th Annual Health Care Conference
Date and time: March 3, 2028; 11:10am EST / 4:10pm GMT
Location: Boston, MA
Presenter: Chief Executive Officer Dr. Christian Itin

A webcast of the presentation will be available on the “Events” page in the “Investor Relations & Media” section of the Company’s website at https://www.autolus.com/investor-relations-media/events/. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

Jefferies Biotech on the Beach Summit
Management to host investor meetings
Date: March 10, 2026
Location: Miami, FL

About Autolus Therapeutics plc
Autolus Therapeutics plc (Nasdaq: AUTL) is a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation T cell therapies and candidates for the treatment of cancer and autoimmune disease. Using a broad suite of proprietary and modular T cell programming technologies, Autolus is engineering precisely targeted and controlled T cell therapies that are designed to better recognize target cells, break down their defense mechanisms and eliminate these cells. Autolus has a marketed therapy, AUCATZYL®, and a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. For more information, please visit www.autolus.com

Contact:  

Amanda Cray 
+1 617-967-0207 
a.cray@autolus.com 


FAQ

When will Autolus (AUTL) present at the TD Cowen 46th Annual Health Care Conference?

Autolus will present on March 3, 2028 at 11:10am EST / 4:10pm GMT. According to the company, CEO Dr. Christian Itin will present and a live webcast will be available on the company Events page, with a replay archived for 90 days.

Where can investors watch the Autolus (AUTL) TD Cowen presentation webcast?

Investors can watch the webcast on the company’s Events page on the investor relations website. According to the company, the presentation will be webcast live and a replay will be archived on the website for 90 days after the event.

What is Autolus (AUTL) doing at the Jefferies Biotech on the Beach Summit?

Autolus management will host investor meetings at the summit on March 10, 2026 in Miami, FL. According to the company, these are management-hosted one-on-one or group investor meetings rather than a public presentation.

Who is presenting for Autolus (AUTL) at the TD Cowen conference?

The presenter will be CEO Dr. Christian Itin. According to the company, Dr. Itin will lead the presentation and management will make the webcast available on the investor Events page with a 90-day replay archive.

How long will the Autolus (AUTL) TD Cowen webcast replay be available online?

The company will archive the replay for 90 days after the presentation. According to the company, the replay will be accessible via the investor relations Events page on the Autolus website for that 90-day period.
AUTOLUS THERAPEUTICS PLC

NASDAQ:AUTL

AUTL Rankings

AUTL Latest News

AUTL Latest SEC Filings

AUTL Stock Data

484.38M
246.72M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United Kingdom
LONDON